Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

• Expected costs and benefits of genetic counselling and germline genetic testing in metastatic prostate cancer

  2026 Human Genetics article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

  0

  citations
• A comprehensive and accessible model for co-segregation analysis in BRCA1, BRCA2, and PALB2 variant classification

  2026 Human Genetics article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

  0

  citations
• Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study

  2026 European Urology article Medicine Prostate Cancer Diagnosis and Treatment Open access

  5

  citations
• Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer

  2025 British Journal of Urology article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

  3

  citations
• A Comprehensive and Accessible Model for Co-Segregation Analysis in BRCA1, BRCA2 , and PALB2 Variant Classification

  2024 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

  1

  citations
• Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relatives

  2024 Familial Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

  3

  citations
• Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting

  2023 European Urology Open Science article Medicine Prostate Cancer Treatment and Research Open access

  10

  citations
• Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study

  2022 BMC Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

  14

  citations
• Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

  2022 Annals of Oncology article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

  296

  citations
• The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care—A Systematic Review

  2022 Cancers review Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

  82

  citations
• Lessons Learned from Setting Up a Prospective, Longitudinal, Multicenter Study with Women at High Risk for Breast Cancer

  2020 Cancer Epidemiology Biomarkers & Prevention article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

  19

  citations
• Characterization of the Cancer Spectrum in Men With GermlineBRCA1andBRCA2Pathogenic Variants

  2020 JAMA Oncology article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

  67

  citations
• Screening naar prostaatkanker bij mannen met een BRCA2 mutatie: adviezen voor de praktijk gebaseerd op resultaten van internationale studie

  2020 Tijdschrift voor Urologie book-chapter Medicine Prostate Cancer Diagnosis and Treatment Open access

  4

  citations

13 results